Efficacy of dexamethasone intravitreal implant combined with anti-VEGF drugs in the treatment of diabetic macular edema: a systematic review and meta-analysis
DEX combined with anti-VEGF agents confers superior anatomical outcomes in reducing CMT compared to anti-VEGF monotherapy in the management of DME. However, further large-scale, multicenter randomized controlled trials with extended follow-up are warranted to validate these findings and optimize treatment protocols.
Authors
- X Wang
- Yiping Xian
- Ming Chen (ORCID: https://orcid.org/0000-0001-5405-4969)
- Mei Xin
- Fang Chen
Institutions
- First Affiliated Hospital of Chengdu Medical College (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2026-01-05
- DOI
- https://doi.org/10.3389/fendo.2025.1673371
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00